Factors associated with adherence in a cohort of HIV positive subjects on a first time PI [protease inhibitor] containing HAART regimen: observational study of the impact of adherence on viral load for a HAART regimen containing Kaletra [lopinavir/ritonavir] vs other selected PI containing HAART

Trial Profile

Factors associated with adherence in a cohort of HIV positive subjects on a first time PI [protease inhibitor] containing HAART regimen: observational study of the impact of adherence on viral load for a HAART regimen containing Kaletra [lopinavir/ritonavir] vs other selected PI containing HAART

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2008

At a glance

  • Drugs Antiretrovirals; HIV protease inhibitors; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 19 Nov 2008 Status changed from completed to discontinued, according to clinicaltrials.gov.
    • 17 Dec 2007 Status changed from in progress to completed.
    • 26 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top